Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
23.65
+0.72 (3.16%)
Oct 8, 2025, 12:13 PM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Dermatologic
257.00M
Log In
Log In
Log In
Log In
Upgrade
Dermatologic Growth
40.15%
Log In
Log In
Log In
Log In
Upgrade
Non-Dermatologic
75.07M
Log In
Log In
Log In
Log In
Upgrade
Non-Dermatologic Growth
106.17%
Log In
Log In
Log In
Log In
Upgrade
Diagnostic and Prognostic Cancer Test
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostic and Prognostic Cancer Test Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
332.07M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
51.09%
Log In
Log In
Log In
Log In
Upgrade